Functional neuroendocrine tumors of the pancreas: From diagnosis to management (notice n° 1528661)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01707cam a2200205 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20251012013202.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Perrier, Marine |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Functional neuroendocrine tumors of the pancreas: From diagnosis to management |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2025.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 29 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The presence of a functional syndrome must be sought when diagnosing a pancreatic neuroendocrine tumor, because its complications can be life-threatening, impair quality of life, and impact survival. When a functional syndrome is suspected, hormonal and/or peptide assays must be performed urgently, concomitantly with the topographical diagnosis of the neuroendocrine tumor and the staging assessment. Specific antisecretory treatment is often urgent: diazoxide for insulinoma, high-dose proton pump inhibitors for gastrinoma, somatostatin analogues for VIPoma or glucagonoma. Curative resection should always be considered in cases of localized and sporadic functional pancreatic neuroendocrine tumor. Management is multimodal, combining dietary measures and nutritional support, patient education, the antisecretory treatment, and an antitumor treatment. This mini review provides an update on the diagnosis and management of the main functional pancreatic neuroendocrine tumors. |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Deguelte, Sophie |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Brixi, Hedia |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Decoudier, Bénédicte |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cadiot, Guillaume |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Hépato-Gastro & Oncologie Digestive | 32 | 5 | 2025-06-12 | p. 396-405 | 2115-3310 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-hepato-gastro-oncologie-digestive-2025-5-page-396?lang=en&redirect-ssocas=7080">https://shs.cairn.info/journal-hepato-gastro-oncologie-digestive-2025-5-page-396?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux